Pat Soon-Shiong/immunitybio.com/
Jul 12, 2025, 08:19
Pat Soon-Shiong: We Should Learn from the UK MHRA Reviewers About Time of Review to Approval
Pat Soon-Shiong, Chairman of Chan Soon-Shiong Family Foundation, Executive Chairman ImmunityBio, Executive Chairman of Los Angeles Times, shared a post on X:
“When regulatory agencies have the interest of the patients in mind innovation happens and lives are saved.
The UK MHRA reviewers took just 4.5 months from time of review to approval.
More posts featuring MHRA.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jul 19, 2025, 16:48
Jul 19, 2025, 16:41
Jul 19, 2025, 16:06
Jul 19, 2025, 16:04
Jul 19, 2025, 15:58
Jul 19, 2025, 15:44